×
About 320 results

ALLMedicine™ Ochronosis Center

Research & Reviews  110 results

Study of Alkaptonuria
https://clinicaltrials.gov/ct2/show/NCT00005909

Jun 24th, 2022 - Alkaptonuria is a rare autosomal recessive disorder in which homogentisic acid accumulates and destroys connective tissue and bone, creating a condition called ochronosis. Symptoms generally begin in the third or fourth decade and progress to inca...

Online Information About Hydroquinone: An Assessment of Accuracy and Readability
https://www.mdedge.com/dermatology/article/255413/aesthetic-dermatology/online-information-about-hydroquinone-assessment
Stephanie Ishack, PhD, Shari R. Lipner, MD, PhD

Jun 14th, 2022 - To the Editor: The internet is a popular resource for patients seeking information about dermatologic treatments. Hydroquinone (HQ) cream 4% is approved by the US Food and Drug Administration for skin hyperpigmentation.

Going Beyond Hydroquinone: Alternative Skin Lightening Agents
https://www.mdedge.com/dermatology/article/255255/pigmentation-disorders/going-beyond-hydroquinone-alternative-skin
Nicole C. Syder, BA, Nada Elbuluk, MD, MSc

Jun 7th, 2022 - Disorders of hyperpigmentation—melasma, postinflammatory hyperpigmentation, lichen planus pigmentosus, erythema dyschromicum perstans, and pigmented contact dermatitis, among others—are common and challenging to treat. Although they can affect ind.

Topical options for treating melasma continue to expand
https://www.mdedge.com/dermatology/article/253196/pigmentation-disorders/topical-options-treating-melasma-continue-expand
Doug Brunk

Mar 26th, 2022 - BOSTON – In the opinion of Seemal R. Desai, MD, dermatologists are obligated to tell their patients with melasma that their condition is a chronic disease with no cure.

Mercury and other risks of cosmetic skin lighteners
https://www.mdedge.com/dermatology/article/252882/aesthetic-dermatology/mercury-and-other-risks-cosmetic-skin-lighteners
Naissan O. Wesley, MD

Mar 18th, 2022 - Skin hyperpigmentation – whether it is caused by postinflammatory hyperpigmentation from acne or trauma to the skin, melasma, autoimmune disorders, or disorders of pigmentation – is a condition where treatment is commonly sought after in dermatolo.

see more →

Clinicaltrials.gov  3 results

Study of Alkaptonuria
https://clinicaltrials.gov/ct2/show/NCT00005909

Jun 24th, 2022 - Alkaptonuria is a rare autosomal recessive disorder in which homogentisic acid accumulates and destroys connective tissue and bone, creating a condition called ochronosis. Symptoms generally begin in the third or fourth decade and progress to inca...

Efficacy and Safety of Topical Cysteamine for Postinflammatory Hyperpigmentation
https://clinicaltrials.gov/ct2/show/NCT05206318

Jan 25th, 2022 - Post-inflammatory hyperpigmentation is a common pigmentary skin disorder that is refractory to treatment and troublesome for darker skin individuals. The current treatment with conventional bleaching cream may result in skin irritation and ochrono...

Long-Term Study of Nitisinone to Treat Alkaptonuria
https://clinicaltrials.gov/ct2/show/NCT00107783

Aug 26th, 2021 - Alkaptonuria is a rare metabolic disease in which homogentisic acid (HGA), an intermediary metabolite in tyrosine catabolism, accumulates due to deficiency of the enzyme homogentisic acid oxidase. Patients with alkaptonuria exhibit homogentisic ac...

see more →

News  15 results

Online Information About Hydroquinone: An Assessment of Accuracy and Readability
https://www.mdedge.com/dermatology/article/255413/aesthetic-dermatology/online-information-about-hydroquinone-assessment
Stephanie Ishack, PhD, Shari R. Lipner, MD, PhD

Jun 14th, 2022 - To the Editor: The internet is a popular resource for patients seeking information about dermatologic treatments. Hydroquinone (HQ) cream 4% is approved by the US Food and Drug Administration for skin hyperpigmentation.

Going Beyond Hydroquinone: Alternative Skin Lightening Agents
https://www.mdedge.com/dermatology/article/255255/pigmentation-disorders/going-beyond-hydroquinone-alternative-skin
Nicole C. Syder, BA, Nada Elbuluk, MD, MSc

Jun 7th, 2022 - Disorders of hyperpigmentation—melasma, postinflammatory hyperpigmentation, lichen planus pigmentosus, erythema dyschromicum perstans, and pigmented contact dermatitis, among others—are common and challenging to treat. Although they can affect ind.

Topical options for treating melasma continue to expand
https://www.mdedge.com/dermatology/article/253196/pigmentation-disorders/topical-options-treating-melasma-continue-expand
Doug Brunk

Mar 26th, 2022 - BOSTON – In the opinion of Seemal R. Desai, MD, dermatologists are obligated to tell their patients with melasma that their condition is a chronic disease with no cure.

Mercury and other risks of cosmetic skin lighteners
https://www.mdedge.com/dermatology/article/252882/aesthetic-dermatology/mercury-and-other-risks-cosmetic-skin-lighteners
Naissan O. Wesley, MD

Mar 18th, 2022 - Skin hyperpigmentation – whether it is caused by postinflammatory hyperpigmentation from acne or trauma to the skin, melasma, autoimmune disorders, or disorders of pigmentation – is a condition where treatment is commonly sought after in dermatolo.

Combination Approach to Melasma Treatment Yields Best Results
https://www.staging.medscape.com/viewarticle/937248

Sep 11th, 2020 - When establishing a treatment plan for patients with melasma, counseling them about realistic expectations is key. "It's important that they understand that this is a chronic condition, so it does require long-term maintenance therapy," Arisa E. O...

see more →